Program Description & Educational Objectives

In this activity, experts in diabetes care discuss realistic patient scenarios to illustrate the nuances and complexities involved in managing diabetes in different stages of disease progression in the context of various cardiometabolic risk factors and comorbidities. Practical guidance for individualized treatment planning and implementation is provided.

Upon completion of this activity, participants should be better able to:

• Understand and apply currently recommended treatment goals for type 2 diabetes mellitus and cardiovascular comorbidities
• Motivate patients toward recommended lifestyle intervention strategies for optimal control of diabetes, lipid levels, and blood pressure in patients with diabetes
• Construct evidence-based, individualized treatment plans for patients with type 2 diabetes mellitus and cardiovascular comorbidities, considering the patient characteristics as well as benefits and limitations of various treatment strategies

Target Audience

This activity has been designed to meet the educational needs of primary care physicians and other clinicians involved in managing patients with diabetes and cardiovascular comorbidities.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: August 30, 2011 - August 29, 2012
Time to Complete: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, the University of Florida College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Ralph A. DeFronzo, MD
Professor of Medicine
Chief, Diabetes Division
University of Texas Health Science Center
Deputy Director, Texas Diabetes Institute
San Antonio, Texas

Ralph A. DeFronzo, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Amylin Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; and Takeda Pharmaceuticals North America, Inc.
Grant/Research Support from Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; and Takeda Pharmaceuticals North America, Inc.

Interviewees

Patrick J. Boyle, MD
Emeritus Professor of Medicine
University of New Mexico
Albuquerque, New Mexico
Consultant, Samaritan Health Care
Depoe Bay, Oregon

Patrick J. Boyle, MD, has a financial interest/relationship or affiliation in the form of:
Speakers Bureau participant with Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; and Takeda Pharmaceuticals North America, Inc.

Edward S. Horton, MD
Professor of Medicine
Harvard Medical School
Senior Investigator
Joslin Diabetes Center
Boston, Massachusetts

Edward S. Horton, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Merck & Co., Inc.
Grant/Research Support from Amylin Pharmaceuticals, Inc. and Eli Lilly and Company.
Advisory Board for Amylin Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd; GI Dynamics, Inc.; Gilead; MacroGenics, Inc.; Medtronic; Merck & Co., Inc.; and Takeda Pharmaceuticals North America, Inc.

CME Reviewer

James M. Smith, MD
Clinical Assistant Professor and Program Director
Department of Internal Medicine
University of Florida College of Medicine
Gainesville, Florida

James M. Smith, MD, currently has no financial interests/relationships or affiliations in relation to this activity.

Content Directors

Kadrin Wilfong, MD
PVI, PeerView Institute for Medical Education

Kadrin Wilfong, MD, currently has no financial interests/relationships or affiliations in relation to this activity.

Sabby Muneer, PhD
PVI, PeerView Institute for Medical Education

Sabby Muneer, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.

Sponsorship, Credit & Support

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Florida College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity is jointly sponsored by the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.